3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
40
Thoracic
6
Breast
6
Genitourinary
5
Gastrointestinal
5
Head & Neck
4
Dermatologic
3
CNS
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other neoplasm
1
Other hematologic neoplasm
1
Other
1
NET
1
Lymphoid
1
Endocrine
1
Conditions
Advanced Solid Tumor
130
Advanced Solid Tumors
122
Solid Tumor
101
Mesothelioma, Malignant
48
Solid Tumors
43
Mesothelioma
42
Hematopoietic and Lymphatic System Neoplasm
30
Solid Tumor, Adult
27
Retinoblastoma
20
Pancreatic Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Ovarian Neoplasms
13
Lung Neoplasms
13
Neoplasms
11
Advanced Malignant Solid Tumor
11
Advanced or Metastatic Solid Tumors
10
Solid Tumors, Adult
9
Sarcoma
9
Hematopoietic and Lymphoid System Neoplasm
9
Advanced Malignant Solid Tumors
9
Stomach Neoplasms
8
Solid Tumor Malignancies
8
Neoplasm Metastasis
8
Melanoma
8
Malignant Solid Tumors
8
Malignant Solid Neoplasm
8
Locally Advanced or Metastatic Solid Tumors
8
Kidney Neoplasms
8
Colorectal Neoplasms
8
Advanced/Metastatic Solid Tumors
8
Interventions
pembrolizumab
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Uterine Neoplasms
×
Other solid neoplasm
×
Clear all
NCT05579366
2026-06-03
RAINFOL-01
Genmab
Phase 1/2
Recruiting
884 enrolled